XML 58 R37.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment [Table Text Block] |
Revenue by Reportable Segment | The following table presents revenue for the two reportable segments and disaggregated revenue within the remaining operating segments, included in Other, and Corporate:
(in millions) | 2025 |  | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 204,644 |  |  | $ | 210,019 |  |  | $ | 188,814 |
Global Medical Products and Distribution | 12,636 |  |  | 12,381 |  |  | 12,222 |
Nuclear and Precision Health Solutions | 1,578 |  |  | 1,369 |  |  | 1,197 |
at-Home Solutions | 3,480 |  |  | 2,869 |  |  | 2,584 |
OptiFreight® Logistics | 324 |  |  | 274 |  |  | 240 |
Other | 5,382 |  |  | 4,512 |  |  | 4,021 |
Total segment revenue | 222,662 |  |  | 226,912 |  |  | 205,057 |
Corporate (1) | (84) |  |  | (85) |  |  | (78) |
Total revenue | $ | 222,578 |  |  | $ | 226,827 |  |  | $ | 204,979 |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Disaggregation of Revenue [Table Text Block] |
(in millions) | 2025 |  | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 204,644 |  |  | $ | 210,019 |  |  | $ | 188,814 |
Global Medical Products and Distribution | 12,636 |  |  | 12,381 |  |  | 12,222 |
Nuclear and Precision Health Solutions | 1,578 |  |  | 1,369 |  |  | 1,197 |
at-Home Solutions | 3,480 |  |  | 2,869 |  |  | 2,584 |
OptiFreight® Logistics | 324 |  |  | 274 |  |  | 240 |
Other | 5,382 |  |  | 4,512 |  |  | 4,021 |
Total segment revenue | 222,662 |  |  | 226,912 |  |  | 205,057 |
Corporate (1) | (84) |  |  | (85) |  |  | (78) |
Total revenue | $ | 222,578 |  |  | $ | 226,827 |  |  | $ | 204,979 |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block] | The following table presents revenue by geographic area:
(in millions) | 2025 |  | 2024 |  | 2023
United States | $ | 220,993 |  |  | $ | 225,231 |  |  | $ | 203,440 |
International | 1,669 |  |  | 1,681 |  |  | 1,617 |
Total segment revenue | 222,662 |  |  | 226,912 |  |  | 205,057 |
Corporate (1) | (84) |  |  | (85) |  |  | (78) |
Total revenue | $ | 222,578 |  |  | $ | 226,827 |  |  | $ | 204,979 |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment | The following tables present revenue, expenses, and segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
| 2025
(in millions) | Pharma |  | GMPD |  | Other |  | Total
Segment revenue | $ | 204,644 |  |  | $ | 12,636 |  |  | $ | 5,382 |  |  | $ | 222,662 |
Cost of products sold | 199,999 |  |  | 10,470 |  |  | 4,023 |  |  | 214,492 |
SG&A | 2,387 |  |  | 2,031 |  |  | 843 |  |  | 5,261 |
Total segment expenses | 202,386 |  |  | 12,501 |  |  | 4,866 |  |  | 219,753 |
Segment profit | $ | 2,258 |  |  | $ | 135 |  |  | $ | 516 |  |  | $ | 2,909 |
Corporate (1) |  |  |  |  |  |  | (634) |
Consolidated operating earnings |  |  |  |  |  |  | $ | 2,275 |
| 2024
(in millions) | Pharma |  | GMPD |  | Other |  | Total
Segment revenue | $ | 210,019 |  |  | $ | 12,381 |  |  | $ | 4,512 |  |  | $ | 226,912 |
Cost of products sold | 205,864 |  |  | 10,264 |  |  | 3,367 |  |  | 219,495 |
SG&A | 2,140 |  |  | 2,025 |  |  | 722 |  |  | 4,887 |
Total segment expenses | 208,004 |  |  | 12,289 |  |  | 4,089 |  |  | 224,382 |
Segment profit | $ | 2,015 |  |  | $ | 92 |  |  | $ | 423 |  |  | $ | 2,530 |
Corporate (1) |  |  |  |  |  |  | (1,287) |
Consolidated operating earnings |  |  |  |  |  |  | $ | 1,243 |
| 2023
(in millions) | Pharma |  | GMPD |  | Other |  | Total
Segment revenue | $ | 188,814 |  |  | $ | 12,222 |  |  | $ | 4,021 |  |  | $ | 205,057 |
Cost of products sold | 184,814 |  |  | 10,377 |  |  | 2,990 |  |  | 198,181 |
SG&A | 2,119 |  |  | 1,992 |  |  | 635 |  |  | 4,746 |
Total segment expenses | 186,933 |  |  | 12,369 |  |  | 3,625 |  |  | 202,927 |
Segment profit | $ | 1,881 |  |  | $ | (147) |  |  | $ | 396 |  |  | $ | 2,130 |
Corporate (1) |  |  |  |  |  |  | (1,378) |
Consolidated operating earnings |  |  |  |  |  |  | $ | 752 |
(1)Corporate revenue and expenses consists of the elimination of inter-segment revenue and other revenue and expenses not allocated to the segments.
Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment | The following tables present depreciation and amortization and additions to property and equipment for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions) | 2025 |  | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 185 |  |  | $ | 184 |  |  | $ | 194 |
Global Medical Products and Distribution | 212 |  |  | 205 |  |  | 173 |
Other | 88 |  |  | 79 |  |  | 71 |
Corporate | 305 |  |  | 242 |  |  | 254 |
Total depreciation and amortization | $ | 790 |  |  | $ | 710 |  |  | $ | 692 |
(in millions) | 2025 |  | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 118 |  |  | $ | 76 |  |  | $ | 56 |
Global Medical Products and Distribution | 133 |  |  | 136 |  |  | 191 |
Other | 88 |  |  | 81 |  |  | 52 |
Corporate | 208 |  |  | 218 |  |  | 182 |
Total additions to property and equipment | $ | 547 |  |  | $ | 511 |  |  | $ | 481 |
Assets by Reportable Segment | The following table presents total assets for the two reportable segments and the remaining operating segments, included in Other, and Corporate at June 30:
(in millions) | 2025 |  | 2024 |  |
Pharmaceutical and Specialty Solutions | $ | 37,313 |  |  | $ | 29,149 |  |  |
Global Medical Products and Distribution | 6,889 |  |  | 7,047 |  |  |
Other | 4,045 |  |  | 2,606 |  |  |
Corporate | 4,875 |  |  | 6,319 |  |  |
Total assets | $ | 53,122 |  |  | $ | 45,121 |  |  |
Property and Equipment, Net by Geographic Area | The following table presents property and equipment, net by geographic area:
(in millions) | 2025 |  | 2024 |  |
United States | $ | 2,422 |  |  | $ | 2,106 |  |  |
International | 436 |  |  | 423 |  |  |
Property and equipment, net | $ | 2,858 |  |  | $ | 2,529 |  |  |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of reconciliation of other items from reportable segments to their consolidated amount. Excludes reconciliation of revenue, profit (loss), and assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration